Catalyst Wire Dossier Catalyst Wire Dossier

Liatermin

r-metHuGDNF · Amgen
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Liatermin, covering 2008-01-11 to 2010-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin [Phase 1, Phase 2]

See pricing